Adjuvant Capital
19+Portfolio
Focus on life sciences and global health, investing $10‑$25M in companies targeting high‑burden and neglected diseases.
Where they invest
Geography
Portfolio footprintHover a country to explore
- United States of America
- 41.7%
- Switzerland
- 16.7%
- United Kingdom
- 8.3%
Darker countries represent a larger share of the portfolio.
What they back
Industries
- Biotechnology
- 75.0%
- Digital Health
- 8.3%
- Consumer Goods
- 8.3%
% of all portfolio companies. Industry categories can overlap.
Stages
Stage indicator
No stages listed
Fund details
Check sizes
Min: $10M
Typical: $17.5M
Max: $25M